These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15015070)

  • 1. Pulse cyclophosphamide therapy in steroid-dependent nephrotic syndrome.
    Prasad N; Gulati S; Sharma RK; Singh U; Ahmed M
    Pediatr Nephrol; 2004 May; 19(5):494-8. PubMed ID: 15015070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulse cyclophosphamide therapy in frequently relapsing nephrotic syndrome.
    Gulati S; Pokhariyal S; Sharma RK; Elhence R; Kher V; Pandey CM; Gupta A
    Nephrol Dial Transplant; 2001 Oct; 16(10):2013-7. PubMed ID: 11572890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized Controlled Trial of Intravenous versus Oral Cyclophosphamide in Steroid-resistant Nephrotic Syndrome in Children.
    Shah KM; Ohri AJ; Ali US
    Indian J Nephrol; 2017; 27(6):430-434. PubMed ID: 29217878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous pulse cyclophosphamide--a new regime for steroid resistant focal segmental glomerulosclerosis.
    Gulati S; Kher V
    Indian Pediatr; 2000 Feb; 37(2):141-8. PubMed ID: 10745408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulse cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis.
    Rennert WP; Kala UK; Jacobs D; Goetsch S; Verhaart S
    Pediatr Nephrol; 1999 Feb; 13(2):113-6. PubMed ID: 10228995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
    Gulati A; Sinha A; Gupta A; Kanitkar M; Sreenivas V; Sharma J; Mantan M; Agarwal I; Dinda AK; Hari P; Bagga A
    Kidney Int; 2012 Nov; 82(10):1130-5. PubMed ID: 22763815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome.
    Bajpai A; Bagga A; Hari P; Dinda A; Srivastava RN
    Pediatr Nephrol; 2003 Apr; 18(4):351-6. PubMed ID: 12700961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulse cyclophosphamide therapy in steroid resistant nephrotic syndrome associated with mesangial proliferative glomerulonephritis.
    Al Salloum AA
    Saudi J Kidney Dis Transpl; 2004; 15(2):129-34. PubMed ID: 17642763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous pulse cyclophosphamide therapy in focal segmental glomerulosclerosis.
    Buyukcelik M; Cengiz N; Dursun H; Soran M; Bayazit AK; Noyan A; Anarat A
    Clin Nephrol; 2006 Jan; 65(1):7-12. PubMed ID: 16429836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulse cyclophosphamide therapy for steroid-resistant focal segmental glomerulosclerosis in children.
    Al Salloum AA
    Ann Saudi Med; 2004; 24(1):27-30. PubMed ID: 15310010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
    Ponticelli C; Edefonti A; Ghio L; Rizzoni G; Rinaldi S; Gusmano R; Lama G; Zacchello G; Confalonieri R; Altieri P
    Nephrol Dial Transplant; 1993; 8(12):1326-32. PubMed ID: 8159300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do glutathione-S-transferase polymorphisms influence response to intravenous cyclophosphamide therapy in idiopathic nephrotic syndrome?
    Sharda SV; Gulati S; Tripathi G; Jafar T; Kumar A; Sharma RK; Agrawal S
    Pediatr Nephrol; 2008 Nov; 23(11):2001-6. PubMed ID: 18594869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
    Chen SY; Wu CY; Tsai IJ; Tsau YK
    Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome.
    Ueda N; Takahashi K; Akioka Y; Morooka M; Ogawa A; Tsuzuki K
    J Nephrol; 2009; 22(5):610-5. PubMed ID: 19809993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous cyclophosphamide is the drug of choice for steroid dependent nephrotic syndrome.
    Bircan Z; Kara B
    Pediatr Int; 2003 Feb; 45(1):65-7. PubMed ID: 12654072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of two unconventional agents in steroid-dependent nephrotic children.
    Donia AF; Ammar HM; El-Agroudy Ael-B; Moustafa Fel-H; Sobh MA
    Pediatr Nephrol; 2005 Oct; 20(10):1420-5. PubMed ID: 16047223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophosphamide treatment in steroid-sensitive nephrotic syndrome of childhood.
    Barratt TM; Bercowsky A; Osofsky SG; Soothill JF
    Lancet; 1975 Jan; 1(7898):55-8. PubMed ID: 46019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cyclophosphamide in idiopathic nephrotic syndrome: Outcome and outlook].
    Berkane M; Adarmouch L; Amine M; Bourrahouat A; Ait Sab I; Sbihi M
    Nephrol Ther; 2018 Apr; 14(2):85-90. PubMed ID: 29631702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
    Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
    Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft für Pädiatrische Nephrologie.
    Arch Dis Child; 1987 Nov; 62(11):1102-6. PubMed ID: 3688915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.